Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer

2015 ◽  
Vol 356 (2) ◽  
pp. 872-879 ◽  
Author(s):  
Dieter J.E. Peeters ◽  
Anja Brouwer ◽  
Gert G. Van den Eynden ◽  
Annemie Rutten ◽  
Wendy Onstenk ◽  
...  
2021 ◽  
Vol 32 ◽  
pp. S31
Author(s):  
M.A. Papadaki ◽  
C.A. Apostolopoulou ◽  
A. Monastirioti ◽  
D. Aggouraki ◽  
C. Papadaki ◽  
...  

2017 ◽  
Vol 77 (12) ◽  
pp. 1291-1298 ◽  
Author(s):  
Arkadius Polasik ◽  
Marie Tzschaschel ◽  
Fabienne Schochter ◽  
Amelie de Gregorio ◽  
Thomas Friedl ◽  
...  

AbstractDissemination of tumour cells and the development of solid metastases occurs via blood vessels and lymphatics. Circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) can be detected in venous blood in patients with early and metastatic breast cancer, and their prognostic relevance has been demonstrated on numerous occasions. Repeated testing for CTCs and ctDNA, or regular so-called “liquid biopsy”, can be performed easily at any stage during the course of disease. Additional molecular analysis allows definition of tumour characteristics and heterogeneity that may be associated with treatment resistance. This in turn makes personalised, targeted treatments possible that may achieve both improved overall survival and quality of life.


2012 ◽  
Vol 13 (7) ◽  
pp. 688-695 ◽  
Author(s):  
Anthony Lucci ◽  
Carolyn S Hall ◽  
Ashutosh K Lodhi ◽  
Anirban Bhattacharyya ◽  
Amber E Anderson ◽  
...  

2009 ◽  
Vol 122 (1) ◽  
pp. 211-217 ◽  
Author(s):  
Edoardo Botteri ◽  
Maria Teresa Sandri ◽  
Vincenzo Bagnardi ◽  
Elisabetta Munzone ◽  
Laura Zorzino ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document